期刊
ORAL AND MAXILLOFACIAL SURGERY CLINICS OF NORTH AMERICA
卷 25, 期 1, 页码 11-+出版社
W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.coms.2012.10.002
关键词
Osteonecrosis; BRONJ; Jaw necrosis; Bisphosphonates; Bone remodeling; Antiresorptive treatment
Since the first description of bone necrosis in patients receiving bisphosphonate therapy in 2004, there have been multiple retrospective, prospective, and case-control studies that have served to characterize the diagnosis, associated risk factors, and treatment of this new complication. Bisphosphonate-related osteonecrosis of the jaw is at present associated with several risk factors that are identified across several disciplines in medicine and dentistry. With this level of broad-based recognition, new clinical and basic science research initiatives have begun and are likely to elucidate the etiopathogenesis of this disease process, significantly improving the level of disease management and prevention.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据